🔎 Trials Near Me

Dachaigh › Osteosarcoma › Michigan

Sgrùdaidhean clionaigeach Osteosarcoma ann an Michigan

Tha 6 sgrùdaidhean airson Osteosarcoma a’ lorg phàirtichean aig làraichean ann an Michigan.

Bailtean ann an Michigan

Teacsa sgrùdaidh oifigeil (Beurla)

Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor

  • C S Mott Children's Hospital, Ann Arbor
A’ fastadhÌre 2
Aoisean 12 gu 39 · Gach gnè · Air ùrachadh 29 Sult 2026 · NCT04616560

Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors

  • Children's Hospital of Michigan/Wayne State University, Detroit
A’ fastadhÌre 1/2
Suas gu aois 30 · Gach gnè · Air ùrachadh 3 Sult 2026 · NCT06541262

Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma

  • C S Mott Children's Hospital, Ann Arbor
  • University of Michigan Rogel Cancer Center, Ann Arbor
  • Bronson Battle Creek, Battle Creek
  • agus 16 a bharrachd
A’ fastadhÌre 3
Suas gu aois 50 · Gach gnè · Air ùrachadh 25 Lùna 2026 · NCT05235165

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

  • C S Mott Children's Hospital, Ann Arbor
A’ fastadhÌre 1/2
12 Months – 30 Years · Gach gnè · Air ùrachadh 25 Lùna 2026 · NCT04851119

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

  • Ascension Saint John Hospital, Detroit
A’ fastadhSgrùdadh amharc
Gach aois · Gach gnè · Air ùrachadh 18 Cèit 2026 · NCT01790152

A Study to Evaluate the Utilization of 3D Printed Models in Pre-Operative Planning

  • William Beaumont University Hospital, Royal Oak
A’ fastadh
Aoisean 13 agus nas sine · Gach gnè · Air ùrachadh 6 Gearr 2026 · NCT06387485

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.